E-LIB Suche - Ergebnisse für: Urigüen, L.

1

Behavioural evaluation and assessment of the Akt/mTOR pathw..:

Unzueta-Larrinaga, P. ; Barrena-Barbadillo, R. ; Iñiguez, S....
Neuroscience Applied. 2 (2023) - p. 103577 , 2023

Link: https://doi.org/10.1016/..

2

Obtaining neurons and glia from the olfactory neuroepitheli..:

Unzueta-Larrinaga, P. ; Barrena-Barbadillo, R. ; Callado, L.F..
Neuroscience Applied. 2 (2023) - p. 101026 , 2023

Link: https://doi.org/10.1016/..

3

Metabolomic analysis of plasma samples from schizophrenia p..:

Callado, L.F. ; Villate, A. ; Olivares, M....
Neuroscience Applied. 2 (2023) - p. 103720 , 2023

Link: https://doi.org/10.1016/..

4

Transcriptomic fingerprint of neurons and glial cells isola..:

Urigüen, L. ; Unzueta-Larrinaga, P. ; Barrena-Barbadillo, R....
Neuroscience Applied. 2 (2023) - p. 103672 , 2023

Link: https://doi.org/10.1016/..

5

P.0907 Cannabis abuse differently regulates 5-HT2A receptor..:

Unzueta-Larrinaga, P. ; Ibarra-Lecue, I. ; Barrena-Barbadillo, R....
European Neuropsychopharmacology. 53 (2021) - p. S666-S667 , 2021

Link: https://doi.org/10.1016/..

6

Decreased ribosomal protein S6 phosphorylation in post-mort..:

Callado, L.F. ; Ibarra-Lecue, I. ; Diez-Alarcia, R...
European Neuropsychopharmacology. 29 (2019) - p. S321 , 2019

Link: https://doi.org/10.1016/..

7

IPR-166: a potent and selective prolyl oligopeptidase inhib..:

Prades, R. ; Munarriz-Cuezva, E. ; Urigüen, L...
European Neuropsychopharmacology. 29 (2019) - p. S244 , 2019

Link: https://doi.org/10.1016/..

8

Chronic tetrahydrocannabinol and psychotic-like symptoms in..:

Ibarra, I. ; Mollinedo-Gajate, I. ; Meana, J.J....
European Neuropsychopharmacology. 28 (2018) - p. S50-S51 , 2018

Link: https://doi.org/10.1016/..

9

Effect of chronic THC administration in the reproductive or..:

López-Cardona, A.P. ; Ibarra-Lecue, I. ; Laguna-Barraza, R....
Biochemical Pharmacology. 157 (2018) - p. 294-303 , 2018

Link: https://doi.org/10.1016/..

10

Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorate..:

Arteaga, Olatz ; Revuelta, M. ; Urigüen, L....
Molecular Neurobiology. 54 (2016) 9 - p. 7137-7155 , 2016

Link: https://doi.org/10.1007/..

11

P.3.c.001 The prolyl oligopeptidase inhibitor IPR19 improve..:

Munarriz-Cuezva, E. ; Prades, R. ; Urigüen, L....
European Neuropsychopharmacology. 25 (2015) - p. S479 , 2015

Link: https://doi.org/10.1016/..

12

P.3.c.002 Selective prolyl oligopeptidase inhibition by IPR..:

Prades, R. ; Munarriza-Cuezva, E. ; Urigüen, L....
European Neuropsychopharmacology. 25 (2015) - p. S479-S480 , 2015

Link: https://doi.org/10.1016/..

13

Behavioral, neurochemical and morphological changes induced..:

Urigüen, L ; Gil-Pisa, I ; Munarriz-Cuezva, E...
Translational Psychiatry. 3 (2013) 1 - p. e221-e221 , 2013

Link: https://doi.org/10.1038/..

14

P.6.b.001 Study of the cannabinoid CB1 receptor funcionalit..:

Callado, L.F. ; Erdozain, A.M. ; Urigüen, L..
European Neuropsychopharmacology. 18 (2008) - p. S527 , 2008

Link: https://doi.org/10.1016/..

15

Gene expression patterns in brain cortex of three different..:

Urigüen, L. ; Arteta, D. ; Díez-Alarcia, R....
Genes, Brain and Behavior. 7 (2008) 6 - p. 649-658 , 2008

Link: https://doi.org/10.1111/..